SARS-CoV-2 vaccinations in children and adolescents with rheumatic diseases
- PMID: 35916712
- PMCID: PMC9384573
- DOI: 10.1093/rheumatology/keac431
SARS-CoV-2 vaccinations in children and adolescents with rheumatic diseases
Comment on
-
Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications.Rheumatology (Oxford). 2022 Nov 2;61(11):4263-4272. doi: 10.1093/rheumatology/keac103. Rheumatology (Oxford). 2022. PMID: 35179569 Free PMC article.
-
Humoral response and safety of BNT162b2 mRNA vaccine in children with rheumatic diseases.Rheumatology (Oxford). 2022 Nov 2;61(11):4482-4490. doi: 10.1093/rheumatology/keac140. Rheumatology (Oxford). 2022. PMID: 35353139 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
